Physiological Effects of 38°C vs. 22°C Fluid Therapy in Critically Ill Patients
Status:
Not yet recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
A randomized controlled clinical trial. 24 adult ICU patients will be recruited upon decision
to administer fluid bolus of 500ml of crystalloid. The fluid will then be randomized to be
infused at controlled room temperature or warmed to body temperature. Hemodynamic
measurements will be made for 2 hours following the bolus, and laboratory values will be
noted. The hypothesis is that part of the hemodynamic response will differed in response to
cooling, and be larger in the cold group.
Phase:
N/A
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Danderyd Hospital Stockholm South General Hospital